Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2010-11-09Clinical Trial Update: Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer
A completed clinical trial report on identifying biomarkers associated with breast cancer risk in women at high or average risk.
-
CLINICAL_TRIALS trial_result · 2010-11-09Clinical Trial Update: Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery [Phase 2]
A Phase 2 clinical trial evaluating docetaxel, epirubicin, and cyclophosphamide with or without trastuzumab in women with locally advanced, …
-
CLINICAL_TRIALS trial_result · 2010-11-05Clinical Trial Update: Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer [Phase 2]
Phase 2 study of dasatinib in patients with advanced ER+/PR+ or HER2+ breast cancer has completed enrollment with results posted.
-
CLINICAL_TRIALS withdrawal · 2010-11-03Clinical Trial Update: Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer [Phase 2]
A Phase 2 trial of an aminoflavone prodrug for breast cancer has been withdrawn.
-
FDA approval · 2010-10-29FDA Approved: HERCEPTIN — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for Herceptin (trastuzumab) submitted by Genentech.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2010-10-29Clinical Trial Update: Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast Cancer [Phase 2]
This Phase 2 trial from Yonsei University evaluates a neoadjuvant regimen of doxorubicin hydrochloride, cyclophosphamide, docetaxel, and S-1…
-
CLINICAL_TRIALS trial_result · 2010-10-28Clinical Trial Update: Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer [Phase 2]
A Phase 2 randomized trial comparing gemcitabine/vinorelbine, gemcitabine/cisplatin, and gemcitabine/capecitabine in metastatic breast cance…
-
FDA approval · 2010-10-20FDA Approved: HERCEPTIN — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for HERCEPTIN (trastuzumab) submitted by Genentech.
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: Comparison of Set-up Reproducibility Between Prone and Supine Intensity Modulated Radiotherapy (IMRT) for the Adjuvant Treatment of Breast Carcinoma After Lumpectomy [NA]
A completed clinical trial comparing setup reproducibility of prone versus supine IMRT for adjuvant breast cancer treatment after lumpectomy…
-
CLINICAL_TRIALS trial_result · 2010-10-13Clinical Trial Update: Study Of Sunitinib With Capecitabine In Breast Cancer [Phase 2]
A Phase 2 study evaluated the combination of sunitinib with capecitabine in patients with advanced or metastatic breast cancer; results were…
-
CLINICAL_TRIALS research · 2010-10-11Clinical Trial Update: Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk
The MSKCC-sponsored clinical trial assessing awareness and attitudes toward prenatal and preimplantation genetic diagnosis for inherited bre…
-
CLINICAL_TRIALS trial_result · 2010-10-08Clinical Trial Update: A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer [Phase 3]
A Phase 3 randomized trial comparing SU011248 plus paclitaxel versus bevacizumab plus paclitaxel in patients with advanced breast cancer has…
-
CLINICAL_TRIALS trial_result · 2010-10-08Clinical Trial Update: A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer [Phase 4]
Phase 4 clinical trial comparing primary prophylaxis with Neulasta (pegfilgrastim) to secondary prophylaxis after chemotherapy in elderly ca…
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer [Phase 1, Phase 2]
An update on a Phase 1/2 clinical trial evaluating high-dose combination chemotherapy followed by peripheral stem cell transplantation in pa…
-
CLINICAL_TRIALS research · 2010-09-28Clinical Trial Update: Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer [Phase 1]
A Phase 1 safety study assessing the combination of trastuzumab and cetuximab in patients with metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients [NA]
A completed clinical trial update examining the emotional needs of caregivers of stem cell transplantation patients is reported.
-
CLINICAL_TRIALS trial_result · 2010-09-16Clinical Trial Update: Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer [Phase 2]
Phase 2 trial evaluating weekly paclitaxel plus carboplatin as preoperative therapy for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2010-09-14Clinical Trial Update: Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis [Phase 2, Phase 3]
Phase 2/3 trial update reporting completion of studies evaluating zoledronic acid (Zometa) in breast cancer patients with bone metastases, i…
-
FDA approval · 2010-09-09FDA Approved: FASLODEX — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for FASLODEX (fulvestrant) from AstraZeneca Pharmaceuticals LP. This action updates the drug's l…
-
CLINICAL_TRIALS trial_result · 2010-09-08Clinical Trial Update: Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating capecitabine in combination with mitomycin C for metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2010-09-06Clinical Trial Update: A Study of Compliant Behaviors and Associated Factors of Women Breast Screening
This completed study examined factors associated with women's compliance with breast cancer screening and related behaviors.
-
CLINICAL_TRIALS trial_result · 2010-09-06Clinical Trial Update: Reducing Arm Morbidity in Pre- and Post-breast Cancer Surgery [NA]
A completed clinical trial sponsored by McGill University evaluating strategies to reduce arm morbidity before and after breast cancer surge…
-
CLINICAL_TRIALS trial_result · 2010-09-06Clinical Trial Update: Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with capecitabine in elderly patients with metastatic breast cancer. The current status of the study is…
-
CLINICAL_TRIALS trial_result · 2010-09-02Clinical Trial Update: Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients
Clinical trial update examining molecular features that predict response or resistance to trastuzumab in metastatic breast cancer, highlight…
-
CLINICAL_TRIALS research · 2010-09-02Clinical Trial Update: Level of HER2-neu Gene Amplification an Response to Trastuzumab
The document discusses a clinical trial investigating whether the level of HER2/neu gene amplification correlates with response to trastuzum…